Literature DB >> 8546754

Association of polymorphisms of the apolipoprotein B gene with coronary heart disease in Han Chinese.

P Ye1, B Chen, S Wang.   

Abstract

Four polymorphic sites of the apolipoprotein B (apo B) gene were investigated by using polymerase chain reaction (PCR) in 103 patients with coronary heart disease (CHD) and 100 age-matched healthy individuals selected from a population of Han Chinese in the Beijing area. The rare X+ allele of the XbaI restriction site was more frequently seen in CHD patients than in controls (0.088 vs. 0.025, P < 0.01). The relative frequency of rare E- allele of the EcoRI restriction site was significantly higher in CHD patients compared with controls (0.11 vs. 0.04, P < 0.01). Similarly, 3'VNTR-L allele (number of repeat units > 39) at the VNTR region was also present at an apparently high frequency in CHD patients in comparison to that in controls (0.602 vs. 0.290, P < 0.001). However, the difference in relative frequency of rare Del allele of the Ins/Del polymorphism at the signal peptide was not significant between the two groups (0.282 vs. 0.235. P > 0.05). In comparison with Caucasians, the relative frequencies of rare alleles (Del, X+ and E-) were found to be statistically lower in Han Chinese. Furthermore, the Del and X+ alleles, in linkage disequilibrium, were associated with significantly lower plasma level of HDL-C in CHD patients. Therefore it is suggested that genetic variation with the apo B gene may exert some impact on lipid metabolism and contribute to the susceptibility to development of CHD in Han Chinese.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546754     DOI: 10.1016/0021-9150(95)05556-c

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  Familial genetic risk factors in premature cardiovascular disease: a family study.

Authors:  Oguzhan Yucel; Oguz Karahan; Ali Zorlu; Sinasi Manduz
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

Review 2.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

3.  Association Between Apolipoprotein B XbaI Polymorphism and Coronary Heart Disease in Han Chinese Population: A Meta-Analysis.

Authors:  Yeda Chen; Meihua Lin; Yan Liang; Naizun Zhang; Shaoqi Rao
Journal:  Genet Test Mol Biomarkers       Date:  2016-05-12

4.  Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men.

Authors:  M O Machado; M H Hirata; M C Bertolami; R D Hirata
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

5.  Higher alleles of apolipoprotein B gene 3' VNTR: Risk for gallstone disease.

Authors:  Manjusha Dixit; Anvesha Srivastava; Gourdas Choudhuri; Balraj Mittal
Journal:  Indian J Clin Biochem       Date:  2008-06-11

6.  Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.

Authors:  Caiqin Niu; Zhi Luo; Liuqin Yu; Yang Yang; Yun Chen; Xin Luo; Feiya Lai; Yongyan Song
Journal:  Lipids Health Dis       Date:  2017-09-06       Impact factor: 3.876

7.  Effect of the 3'APOB-VNTR polymorphism on the lipid profiles in the Guangxi Hei Yi Zhuang and Han populations.

Authors:  Yin Ruixing; Chen Guangqin; Wang Yong; Lin Weixiong; Yang Dezhai; Pan Shangling
Journal:  BMC Med Genet       Date:  2007-07-17       Impact factor: 2.103

8.  Association between the APOB XbaI and EcoRI polymorphisms and lipids in Chinese: a meta-analysis.

Authors:  Wei Gu; Mingduo Zhang; Shaojun Wen
Journal:  Lipids Health Dis       Date:  2015-10-07       Impact factor: 3.876

9.  Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART.

Authors:  Rosmeri K Lazzaretti; Aline S Gasparotto; Marina G de M Sassi; Carísi A Polanczyk; Regina Kuhmmer; Jussara M Silveira; Rossana P Basso; Cezar A T Pinheiro; Mariângela F Silveira; Eduardo Sprinz; Vanessa S Mattevi
Journal:  ScientificWorldJournal       Date:  2013-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.